202 related articles for article (PubMed ID: 1737364)
21. Lack of BCL-2 confers interferon-alpha sensitivity to B-cell lymphomas.
Karauzum SB; Yasar D; Dirice E; Imir N; Luleci G; Ozes ON
Growth Factors; 2007 Apr; 25(2):94-100. PubMed ID: 17852408
[TBL] [Abstract][Full Text] [Related]
22. Alpha-interferon and lymphokine-activated killer cells in hairy cell leukemia.
Griffiths SD; Cawley JC
Leukemia; 1988 Jun; 2(6):377-81. PubMed ID: 3374170
[TBL] [Abstract][Full Text] [Related]
23. Intratumoral interferon-alpha gene transfer enhances tumor immunity after allogeneic hematopoietic stem cell transplantation.
Hara H; Kobayashi A; Narumi K; Kondoh A; Yoshida K; Nishimoto T; Ohashi M; Higashihara E; Ohnami S; Yoshida T; Aoki K
Cancer Immunol Immunother; 2009 Jul; 58(7):1007-21. PubMed ID: 18998126
[TBL] [Abstract][Full Text] [Related]
24. Hairy-cell leukemia. Morphologic, cytochemical, and immunologic features.
Paoletti M; Bitter MA; Vardiman JW
Clin Lab Med; 1988 Mar; 8(1):179-95. PubMed ID: 3282758
[TBL] [Abstract][Full Text] [Related]
25. Leukemic cells in hairy cell leukemia and B cell chronic lymphocytic leukemia release soluble TNF receptors.
Trentin L; Pizzolo G; Zambello R; Agostini C; Morosato L; Sancetta R; Adami F; Vinante F; Chilosi M; Gallati H
Leukemia; 1995 Jun; 9(6):1051-5. PubMed ID: 7596168
[TBL] [Abstract][Full Text] [Related]
26. Combination treatment of 2-chlorodeoxyadenosine and type I interferon on hairy cell leukemia-like cells: cytotoxic effect and MHC-unrestricted killer cell regulation.
Reiter Z; Tomson S; Ozes ON; Taylor MW
Blood; 1993 Apr; 81(7):1699-708. PubMed ID: 8096405
[TBL] [Abstract][Full Text] [Related]
27. Changes in hairy cells after alpha-interferon treatment as measured by flow cytometry.
Huang AT; Mold NG
Leukemia; 1987 Apr; 1(4):308-11. PubMed ID: 3669751
[TBL] [Abstract][Full Text] [Related]
28. Ultrastructural, immunologic and clinical follow-up of five patients with HCL treated with interferon (IFN) for more than three years.
Mantovani G; Astara G; Curreli L; Lai P; Turnu E; Locci F; Lantini MS; Cossu M; Riva A; Del Giacco GS
Haematologica; 1992; 77(4):326-35. PubMed ID: 1427443
[TBL] [Abstract][Full Text] [Related]
29. [Alpha interferon treatment in hairy cell leukemia].
Hagberg H
Nord Med; 1992; 107(3):74-5. PubMed ID: 1347920
[TBL] [Abstract][Full Text] [Related]
30. Cytokine and natural killing regulation of growth of a hairy cell leukemia-like cell line: the role of interferon-alpha and interleukin-2.
Reiter Z; Ozes ON; Blatt LM; Taylor MW
J Immunother (1991); 1992 Jan; 11(1):40-9. PubMed ID: 1734947
[TBL] [Abstract][Full Text] [Related]
31. [Improvement with interferon-alpha therapy and splenectomy in hairy cell leukemia of European-American type].
Yasuyama M; Kawauchi K; Sugiyama H; Mori H; Enomoto Y; Watanabe Y; Machii T; Kitani T
Rinsho Ketsueki; 1992 Mar; 33(3):365-70. PubMed ID: 1578641
[TBL] [Abstract][Full Text] [Related]
32. Investigating hairy cell leukemia dysregulations. Looking for interferon alpha site of action in hairy cells.
Genot E; Wietzerbin J
Leuk Lymphoma; 1994; 14 Suppl 1():23-6. PubMed ID: 7820049
[TBL] [Abstract][Full Text] [Related]
33. Demonstration of the increase in serine esterase-positive T cells in hairy-cell leukemia patients undergoing alpha-interferon therapy.
Wagner L; Goldstone AH; Worman CP
Leukemia; 1989 May; 3(5):373-9. PubMed ID: 2497282
[TBL] [Abstract][Full Text] [Related]
34. Interferon alpha and intracytoplasmic free calcium in hairy cell leukemia cells.
Genot E
Leuk Lymphoma; 1994 Feb; 12(5-6):373-81. PubMed ID: 8180601
[TBL] [Abstract][Full Text] [Related]
35. Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia.
Bigda J; Mysliwska J; Baran W; Hellmann A; Mysliwski A
Leuk Lymphoma; 1993 Mar; 9(4-5):371-6. PubMed ID: 8348073
[TBL] [Abstract][Full Text] [Related]
36. Spectrum of biological activity of interferons.
Battistini A; Affabris E; Fiorucci G; Coccia EM; Romeo G; Marziali G; Rossi GB
Ann Ist Super Sanita; 1990; 26(3-4):227-53. PubMed ID: 1708952
[TBL] [Abstract][Full Text] [Related]
37. Impaired interferon alpha response in hairy cell leukemia is corrected by therapy with 2-chloro-2'-deoxyadenosine: implications for susceptibility to opportunistic infections.
Siegal FP; Shodell M; Shah K; Drake D; Hoffman M; Sawitsky A; Janson D; Fitzgerald-Bocarsly P; Rai KR
Leukemia; 1994 Sep; 8(9):1474-9. PubMed ID: 7916389
[TBL] [Abstract][Full Text] [Related]
38. Proliferative response of hairy cells to B cell growth factor (BCGF): in vivo inhibition by interferon-alpha and in vitro effects of interferon-alpha, -beta, and -gamma.
Genot E; Billard C; Sigaux F; Mathiot C; Degos L; Falcoff E; Kolb JP
Leukemia; 1987 Aug; 1(8):590-6. PubMed ID: 2444836
[TBL] [Abstract][Full Text] [Related]
39. Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events.
Trentin L; Ambrosetti A; Zambello R; Agostini C; Masciarelli M; Vinante F; Chilosi M; Pizzolo G; Cetto G; Semenzato G
Leuk Res; 1987; 11(9):843-7. PubMed ID: 3499539
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 12 augments natural killer-cell mediated cytotoxicity in hairy cell leukemia.
Bigda J; Mysliwska J; Dziadziuszko R; Bigda J; Mysliwski A; Hellmann A
Leuk Lymphoma; 1993 May; 10(1-2):121-5. PubMed ID: 8104069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]